BVS
Bioventus Inc
13.80$
+2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +449.6% | +25.2% | +138.8% | -9.9% | +76.4% | -68.0% | -158.9% | – | +152.8% | +90.7% | |
| – | +17.8% | +14.8% | -11.6% | +3.7% | -5.5% | +21.8% | +58.8% | +3.6% | -13.6% | -5.1% | |
| – | +308.9% | +41.2% | +330.8% | -24.3% | -6.8% | -144.7% | – | -84.5% | +269.5% | +26.0% | |
| – | – | – | +5.6% | -30.1% | -16.4% | -35.2% | – | – | – | – | |
| – | – | – | – | -575.9% | – | -186.7% | – | – | – | – | |
| – | +227.7% | -64.3% | -18.6% | +37.6% | +147.8% | -64.3% | -79.9% | +398.1% | -86.3% | +154.7% | |
| – | +185.3% | +91.8% | -89.9% | +29.7% | +159.1% | +1,284.2% | -59.0% | – | +45.3% | -114.1% | |
| – | -4.1% | -57.6% | +672.2% | +16.5% | +117.6% | -98.2% | +2,389.6% | – | – | – | |
| – | – | – | – | – | – | – | -101.2% | – | – | – | |
| – | – | – | +677.8% | -74.0% | +632.1% | – | -64.1% | -139.0% | +156.1% | -28.0% | |
| – | -197.7% | – | -142.4% | -17.4% | +170.0% | – | -77.3% | -142.9% | +104.8% | +12.6% | |
| – | – | – | – | -15.3% | +2.6% | -44.6% | -644.5% | – | -9.9% | +109.1% | |
| – | – | – | +240.9% | -17.3% | +57.9% | -69.4% | -196.1% | – | +373.4% | +89.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.